Found: 6
Select item for more details and to access through your institution.
A Phase 1 Study to Assess Mass Balance and Absolute Bioavailability of Zimlovisertib in Healthy Male Participants Using a <sup>14</sup>C‐Microtracer Approach.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 7, p. 815, doi. 10.1002/cpdd.1109
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of PF‐06823859, an Anti–Interferon β Monoclonal Antibody: A Randomized, Phase I, Single‐ and Multiple‐Ascending‐Dose Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 3, p. 307, doi. 10.1002/cpdd.887
- By:
- Publication type:
- Article
The Effect of Chelation on Blood Pressure in Lead-Exposed Children: A Randomized Study.
- Published in:
- Environmental Health Perspectives, 2006, v. 114, n. 4, p. 579, doi. 10.1289/ehp.8634
- By:
- Publication type:
- Article
Effect of Succimer on Growth of Preschool Children with Moderate Blood Lead Levels.
- Published in:
- Environmental Health Perspectives, 2004, v. 112, n. 2, p. 233, doi. 10.1289/ehp.6331
- By:
- Publication type:
- Article
Are we Consistent in Administering and Scoring the Bayley Scales of Infant Development-II?
- Published in:
- Journal of Psychoeducational Assessment, 2002, v. 20, n. 2, p. 183, doi. 10.1177/073428290202000206
- By:
- Publication type:
- Article
A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis
- Published in:
- Arthritis Research & Therapy, 2024, v. 26, n. 1, p. 1, doi. 10.1186/s13075-024-03337-2
- By:
- Publication type:
- Article